Summary The 62 kDa protein product of the c-myc oncogene (p62 c-myc) is thought to be involved in the control of normal cellular proliferation and differentiation. We have measured oncoprotein levels using a flow cytometric assay in 141 operable breast cancers and have correlated levels with prognostic variables, patient survival and disease free intervals. High levels of p62 c-myc were associated with well differentiated tumours.
Summary The 62 kDa protein product of the c-myc oncogene (p62 c-myc) is thought to be involved in the control of normal cellular proliferation and differentiation. We have measured oncoprotein levels using a flow cytometric assay in 141 operable breast cancers and have correlated levels with prognostic variables, patient survival and disease free intervals. High levels of p62 c-myc were associated with well differentiated tumours.
There was no correlation with tumour DNA index, lymph node or oestrogen receptor status. C-myc oncoprotein levels were not predictive of patient survival or disease free interval. This relationship of oncoprotein levels with tumour histological grade is in keeping with the suggestion that the c-myc oncogene is important in the control of cellular differentiation. The other findings imply that measurement of c-myc oncoprotein levels does not yield useful prognostic information.
Cellular oncogenes resembling viral oncogenes are present in normal cells where they encode proteins that act as receptors, intracellular signal transducers or growth factors. Oncogene products are thus important in the control of normal cellular development and division. Changes in oncogene expression occur during normal wound repair (Goyette et al., 1983) and embryogenesis (Muller et al., 1982) . Changes in oncogene control and expression may also lead to, or be associated with, malignant transformation.
The c-myc oncoprotein is associated with cell division and differentiation as c-myc mRNA increases as culture cells are stimulated into division (Kelly et al., 1983) . It has a short half-life and has been shown to be nuclear associated (Persson & Leder, 1984) , which is in keeping with a proposed role in cell cycle control. The aim of this study was to confirm that c-myc oncoprotein levels could be quantified in the nuclei of breast cancers. We also wished to determine whether a correlation existed between oncoprotein levels, tumour prognostic factors, patient survival and disease-free interval.
Patients and methods
One hundred and forty-one patients were studied. All had undergone simple or subcutaneous mastectomy as the primary treatment for their breast cancer between 1974 and 1976 at the Nottingham City Hospital. Lymph node sampling was performed in all cases. The nodes sampled were low axillary, apical axillary and internal mammary (via the second interspace) at the time of initial surgery. Three lymph node stages can be identified based on the involvement of nodes with metastatic tumour. These are: stage 1, no nodal involvement; stage 2, low axillary node involvement alone; stage 3, apical or internal mammary node involved alone or in any other combination.
Antibodies to the c-myc oncoprotein have been generated by peptide immunisation . The DNA sequence of the c-myc gene was used to deduce the amino acid sequence of the oncoprotein, and mice were immunised to produce monoclonal antibodies. A number of antibodies have been produced and one of them can be used to detect p62 c-myc in archival pathological material. We have used this antibody (myc 1-6E10) to characterise oncoprotein levels in paraffin embedded primary breast cancer.
We used the technique of simultaneously measuring p62 c-myc and DNA as described in detail by Watson et al. (1985) . In (Elston, 1987) . Grade was assessed by allocation of individual scores from one to three based on increasing severity of three features: nuclear pleomorphism (small regular nuclei, 1; to large nuclei of variable size 3), tubule formation (present in > 75% of the tumour, 1; to present in < 10% of tumour, 3), and mitotic frequency (number seen per 10 high power microscopic fields <10, 1; to >20, 3). The overall grade is derived from summation of the individual scores as follows: 3-5, grade I; 6-7, grade II; 8-9, grade III. With experience intra-observer variability can be reduced to very low levels. With training inter-observer variability can also be reduced to acceptable levels. To confirm the prognostic value of histological grading within this series of patients, survival curves have been constructed for each of the three grades (Figure 2) .
Oncoprotein levels were also correlated with DNA index, lymph node and oestrogen receptor status (ER). ER status was measured by the dextran coated charcoal method (Maynard & Griffiths, 1978) , a value of >5 fmol mg-' cytosol protein being considered positive.
Life table analysis (Goldstone, 1985) was used to construct survival curves, with Mantel's analysis (Mantel, 1966) to compare the difference between groups.
Results
The range of measured green fluorescence for the 141 tumours was 2.3-480 fluorescence units (median 49.2 FU). Examples of bivariate analysis of c-myc staining (green fluorescence) against DNA staining (red fluorescence) for both diploid and an aneuploid tumour are seen in Figure 1 .
For subsequent analysis the c-myc staining (green fluorescence values) were divided into tertile groups (i.e. 47 tumours in each) deemed low, moderate and high. (9) a 0 levels and tumour grade: lower levels of p62 c-myc being associated with a poorer grade P<0.05 (Table I) . DNA index Eighty-four patients had diploid tumours (DNA index = 1.0), 57 patients had aneuploid tumours (DNA index> 1.0). There was no correlation between DNA index and p62 c-myc levels (Table II) (Table IV) .
Survival
Life table analysis demonstrates no significant association between overall patient survival or disease-free interval and tumour oncoprotein levels (Figures 3 and 4) . In normal resting cells oncogenes appear to be transcribed at low levels (Hamlyn & Sikora, 1983) and this can make the study of their products difficult. The c-myc oncogene product has, however, been quantified by immunohistological methods and by flow techniques as utilised by us but previously described in detail elsewhere . This study has confirmed that the c-myc protein product can be quantified in archival breast cancer using flow cytometry.
The c-myc oncogene is thought to be important in controlling cell division and differentiation in both normal and malignant tissue. Following partial hepatectomy and during differentiations of marrow stem cells differing oncogene transcriptional patterns have been noted (Hamlyn & Sikora, 1983) . Large quantities of p62 c-myc oncoprotein occur transiently during the normal differentiation of testicular germ cells. A number of studies (Greenberg & Ziff, 1984; Kelly et al., 1984; Makino et al., 1984; Hann et al., 1985; Thompson et al., 1985; Rabbitts et al., 1985; Stewart et al., 1986) where the most undifferentiated teratomas contained low levels of c-myc oncoprotein. Low levels of c-myc oncoprotein have also been shown to be associated with poorly differentiated colonic tumours 
